ERBB4 inhibition also increases tumor cells’ vulnerability prior to chemotherapy treatment in neuroblastoma [27] and in lung cancer [28], but little is known about its role in cerebellar development and medulloblastoma. Here, ERBB4 is linked to medulloblastoma.